Quest Diagnostics to Acquire University Hospital’s Outreach Laboratory Assets

This move will bolster Quest’s presence in Ohio, enabling it to extend its diagnostic services across a broader network within the state.

US-based Quest Diagnostics has acquired select assets from University Hospital’s outreach laboratory services. 

This move is expected to bolster Quest’s presence in Ohio, enabling it to extend its diagnostic services across a broader network within the state.

The acquisition is set to enhance Quest Diagnostics’ ability to provide laboratory services throughout Ohio. 

Sharing thoughts, Cliff A Megerian, CEO, University Hospitals, said,  “Laboratory testing is a critical and increasingly complex area of healthcare and Quest is a trusted name in laboratory services known for high quality and innovation."

The CEO continued to add that collaboration will maintain streamlined and efficient operations, quality and breadth of menu while enhancing access for our patients

Jim Davis, CEO, chairman, and president, Quest Diagnostics said, “Top health systems like University Hospitals are transitioning their laboratory services to Quest in order to improve operating efficiency and ensure continued access to affordable care. Our specialization and scale empower us to optimize lab services for quality, innovation and affordability, enabling health systems to dedicate more resources to clinical patient care."

Recent Developments

This acquisition follows Quest Diagnostics’ recent announcement of 13 new blood tests aimed at identifying micronutrient deficiencies. These tests, available through consumer-initiated blood-draw options, are designed to assess essential nutrients such as iron, calcium, and magnesium. 

Dr Katrina Sutto, PharmD, Medical Science Liaison of consumer-initiated testing for Quest Health, said, “Studies have shown that key vitamins and nutrients such as iron, calcium, and magnesium are under-consumed or may be poorly absorbed in the body, which may have an adverse effect on people's health. What people may not realize is that their medications, allergies, chronic conditions and diets can affect how well their bodies can absorb these essential nutrients. In providing medically-informed testing solutions and detailed results through our various nutrient panels, we hope to empower people to seek the best pathway to help their overall wellbeing.”

In addition to the acquisition and new testing services, Quest Diagnostics recently released a study highlighting gaps in testing for sexually transmitted infections (STIs) among pregnant women in the United States. 

The study indicates that there is inadequate adherence to existing STI testing recommendations. 

Dr Damian P Alagia, MD, medical director of Women’s Health at Quest Diagnostics, said, “Our analysis shows that improved adherence to existing recommendations, harmonization of guidelines across agencies, and even updated recommendations for STI testing will be critical to ensuring the mothers and babies in the United States receive medically appropriate testing and treatment."